Epygen plans to raise Rs 300 cr to propel biosimilars in India
The funds will be utlilised for clinical trials of pipeline molecules and securing IP for technologies for novel biological…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.